Sfoglia per Autore
S-adenosil-L-methionine is able to reverse the immunosuppressive effects of chenodeoxycholic acid in vitro.
1997-01-01 Filaci, Gilberto; Pelli, N; Sacco, T; Contini, Paola; Lanza, L; Picciotto, Antonino; Scudeletti, M; Puppo, Francesco; Castiglioni, G; Indiveri, Francesco
Serum intercellular adhesion molecule-1 and long-term response to IFN-alpha2b therapy in chronic hepatitis C
1998-01-01 Bagnasco, Marcello; Riccio, ANNA MARIA; Sinelli, N.; Campo, N.; Battifora, M.; Canonica, Giorgio; Picciotto, Antonino
Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients.
1999-01-01 N., Campo; N., Sinelli; Brizzolara, Renata; Torre, Francesco; Gurreri, Giovanna; R., Russo; S., Saffioti; Celle, Guido; Picciotto, Antonino
Probability of non-response during interferon therapy in patients with chronic hepatitis C
1999-01-01 Testa, Roberto; Giannini, EDOARDO GIOVANNI; Picciotto, Antonino; Risso, Domenico; Caglieris, S; Fasoli, A; Lantieri, Pasquale; Icardi, Giancarlo; Lapertosa, G; Celle, G.
Chronic hepatitis C. New therapeutic strategies.
1999-01-01 Picciotto, Antonino; Torre, Francesco; Brizzolara, R; Campo, N; Giusto, R; Sinelli, N; Lantieri, Bp; Risso, D; Celle, G.
Interferon retreatment in chronic hepatitis C: wich patients to choose, and what schedule to use
1999-01-01 Picciotto, Antonino; N., Campo; Brizzolara, Renata; N., Sinelli; Torre, Francesco; A., GIUDICI CIPRIANI; I., Ponassi; G., Varagona; A., Grasso; P., DE LEO; V., DE CONCA; S., Mesiti; G., Marenco; G., Menardo; M., Dodero; Celle, Guido
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.
2000-01-01 Puppo, Francesco; Torre, Francesco; Contini, Paola; Ghio, M; Brenci, S; Brizzolara, Renata; Sinelli, N; Campo, N; Indiveri, Francesco; Picciotto, Antonino
TT virus infection in haemodialysis patients
2000-01-01 Campo, N; Brizzolara, Renata; Sinelli, N; Torre, Francesco; Russo, R; Deferrari, Giacomo; Picciotto, Antonino
Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis.
2000-01-01 Torre, Francesco; Campo, N; Sinelli, N; Brizzolara, R; Andorno, E; Valente, U; Picciotto, Antonino
Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.
2000-01-01 Puppo, Francesco; Brenci, S; Contini, Paola; Bignardi, D; Hamby, Cv; Filaci, Gilberto; Ghio, M; Scudeletti, M; Picciotto, Antonino; Indiveri, Francesco; Ferrone, S.
Evaluation of a new hepatitis C virus sequecing assay as a routine method for genotyping
2001-01-01 Ansaldi, Filippo; Torre, Francesco; Bruzzone, B. M.; Picciotto, Antonino; Crovari, Pietro; Icardi, Giancarlo
Prospective evaluation of primary infection due to HCV, HGV or TTV in children with newly diagnosed neoplasia.
2001-01-01 Tasso, L; Castagnola, E; Lo Giudice, C; Torre, Francesco; Micalizzi, C; Picciotto, Antonino; Giacchino, R.
Clearance kinetics of hepatitis C virus under different antiviral therapies.
2001-01-01 Torre, Francesco; Giusto, R; Grasso, A; Brizzolara, R; Campo, N; Sinelli, N; Balestra, V; Picciotto, Antonino
Antiviral activity of amantadine in elderly patients with chronic hepatitis C
2001-01-01 Torre, Francesco; Campo, N.; Giusto, R.; Ansaldi, Filippo; Icardi, Giancarlo; Picciotto, Antonino
Amantadine: a different approach.
2002-01-01 Torre, Francesco; Picciotto, Antonino
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects?
2003-01-01 Icardi, Giancarlo; Bruzzone, B.; Gota, F.; Torre, Francesco; Giannini, EDOARDO GIOVANNI; Massone, L.; LI BASSI, A.; Lai, PIERO LUIGI; Picciotto, Antonino; Ansaldi, Filippo
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.
2004-01-01 Torre, Francesco; Rossol, S; Pelli, N; Basso, M; Delfino, A; Picciotto, Antonino
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant
2004-01-01 Torre, Francesco; Mattioli, Francesca; Campo, N.; Delfino, A.; Basso, M.; Pelli, N.; Martelli, ANTONIETTA MARIA; Picciotto, Antonino
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.
2005-01-01 Basso, M.; Torre, Francesco; Picciotto, Antonino
Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C.
2005-01-01 Pellicano, R; Craxi, A; Almasio, Pl; Valenza, M; Venezia, G; Alberti, A; Boccato, S; Demelia, L; Sorbello, O; Picciotto, Antonino; Torre, Francesco; Ideo, G; Cattaneo, C; Berrutti, M; Rizzetto, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
S-adenosil-L-methionine is able to reverse the immunosuppressive effects of chenodeoxycholic acid in vitro. | 1-gen-1997 | Filaci, Gilberto; Pelli, N; Sacco, T; Contini, Paola; Lanza, L; Picciotto, Antonino; Scudeletti, M; Puppo, Francesco; Castiglioni, G; Indiveri, Francesco | |
Serum intercellular adhesion molecule-1 and long-term response to IFN-alpha2b therapy in chronic hepatitis C | 1-gen-1998 | Bagnasco, Marcello; Riccio, ANNA MARIA; Sinelli, N.; Campo, N.; Battifora, M.; Canonica, Giorgio; Picciotto, Antonino | |
Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients. | 1-gen-1999 | N., Campo; N., Sinelli; Brizzolara, Renata; Torre, Francesco; Gurreri, Giovanna; R., Russo; S., Saffioti; Celle, Guido; Picciotto, Antonino | |
Probability of non-response during interferon therapy in patients with chronic hepatitis C | 1-gen-1999 | Testa, Roberto; Giannini, EDOARDO GIOVANNI; Picciotto, Antonino; Risso, Domenico; Caglieris, S; Fasoli, A; Lantieri, Pasquale; Icardi, Giancarlo; Lapertosa, G; Celle, G. | |
Chronic hepatitis C. New therapeutic strategies. | 1-gen-1999 | Picciotto, Antonino; Torre, Francesco; Brizzolara, R; Campo, N; Giusto, R; Sinelli, N; Lantieri, Bp; Risso, D; Celle, G. | |
Interferon retreatment in chronic hepatitis C: wich patients to choose, and what schedule to use | 1-gen-1999 | Picciotto, Antonino; N., Campo; Brizzolara, Renata; N., Sinelli; Torre, Francesco; A., GIUDICI CIPRIANI; I., Ponassi; G., Varagona; A., Grasso; P., DE LEO; V., DE CONCA; S., Mesiti; G., Marenco; G., Menardo; M., Dodero; Celle, Guido | |
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment. | 1-gen-2000 | Puppo, Francesco; Torre, Francesco; Contini, Paola; Ghio, M; Brenci, S; Brizzolara, Renata; Sinelli, N; Campo, N; Indiveri, Francesco; Picciotto, Antonino | |
TT virus infection in haemodialysis patients | 1-gen-2000 | Campo, N; Brizzolara, Renata; Sinelli, N; Torre, Francesco; Russo, R; Deferrari, Giacomo; Picciotto, Antonino | |
Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis. | 1-gen-2000 | Torre, Francesco; Campo, N; Sinelli, N; Brizzolara, R; Andorno, E; Valente, U; Picciotto, Antonino | |
Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens. | 1-gen-2000 | Puppo, Francesco; Brenci, S; Contini, Paola; Bignardi, D; Hamby, Cv; Filaci, Gilberto; Ghio, M; Scudeletti, M; Picciotto, Antonino; Indiveri, Francesco; Ferrone, S. | |
Evaluation of a new hepatitis C virus sequecing assay as a routine method for genotyping | 1-gen-2001 | Ansaldi, Filippo; Torre, Francesco; Bruzzone, B. M.; Picciotto, Antonino; Crovari, Pietro; Icardi, Giancarlo | |
Prospective evaluation of primary infection due to HCV, HGV or TTV in children with newly diagnosed neoplasia. | 1-gen-2001 | Tasso, L; Castagnola, E; Lo Giudice, C; Torre, Francesco; Micalizzi, C; Picciotto, Antonino; Giacchino, R. | |
Clearance kinetics of hepatitis C virus under different antiviral therapies. | 1-gen-2001 | Torre, Francesco; Giusto, R; Grasso, A; Brizzolara, R; Campo, N; Sinelli, N; Balestra, V; Picciotto, Antonino | |
Antiviral activity of amantadine in elderly patients with chronic hepatitis C | 1-gen-2001 | Torre, Francesco; Campo, N.; Giusto, R.; Ansaldi, Filippo; Icardi, Giancarlo; Picciotto, Antonino | |
Amantadine: a different approach. | 1-gen-2002 | Torre, Francesco; Picciotto, Antonino | |
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? | 1-gen-2003 | Icardi, Giancarlo; Bruzzone, B.; Gota, F.; Torre, Francesco; Giannini, EDOARDO GIOVANNI; Massone, L.; LI BASSI, A.; Lai, PIERO LUIGI; Picciotto, Antonino; Ansaldi, Filippo | |
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin. | 1-gen-2004 | Torre, Francesco; Rossol, S; Pelli, N; Basso, M; Delfino, A; Picciotto, Antonino | |
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant | 1-gen-2004 | Torre, Francesco; Mattioli, Francesca; Campo, N.; Delfino, A.; Basso, M.; Pelli, N.; Martelli, ANTONIETTA MARIA; Picciotto, Antonino | |
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. | 1-gen-2005 | Basso, M.; Torre, Francesco; Picciotto, Antonino | |
Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C. | 1-gen-2005 | Pellicano, R; Craxi, A; Almasio, Pl; Valenza, M; Venezia, G; Alberti, A; Boccato, S; Demelia, L; Sorbello, O; Picciotto, Antonino; Torre, Francesco; Ideo, G; Cattaneo, C; Berrutti, M; Rizzetto, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile